Salzmann Stefan, de Vroege Lars, Engelmann Petra, Fink Per, Fischer Susanne, Frisch Stephan, Gormsen Lise Kirstine, Hüfner Katharina, Kop Willem J, Köteles Ferenc, Lehnen Nadine, Löwe Bernd, Pieh Christoph, Pitron Victor, Rask Charlotte Ulrikka, Sainio Markku, Schaefert Rainer, Shedden-Mora Meike, Toussaint Anne, von Känel Roland, Werneke Ursula, Rief Winfried
Division of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Gutenbergstraße 18, Marburg, 35032, Germany.
Medical Psychology, Health and Medical University Erfurt, Erfurt, Germany.
BMC Med. 2025 Feb 11;23(1):81. doi: 10.1186/s12916-025-03927-0.
Harmonizing core outcome domains allows for pooling data, comparing interventions, and streamlining research evaluation. At the same time clinicians require concise and feasible measures for routine practice. Considering the heterogeneity of post-COVID-19 condition, a biopsychosocial approach requires sufficient coverage of the psychosocial dimension with assessments. Previous recommendations for core outcome sets have serious limitations regarding the psychosocial aspects of post-COVID-19 condition. This paper specifically focuses on psychosocial outcomes for adults with post-COVID-19 condition, providing both a comprehensive set of outcome domains for research and a streamlined clinical core set tailored for routine clinical use.
In a structured Consensus Development Approach, the European Network to improve diagnostic, treatment, and healthcare for patients with persistent somatic symptoms (EURONET-SOMA) developed psychosocial core outcome domains and assessments regarding post-COVID-19 condition. The experts identified variables and instruments which should be considered in studies on adults suffering from post-COVID-19 condition, and which are feasible in the clinical setting and relevant for research.
We identified three higher-order dimensions with each encompassing several domains: The first higher-order dimension, "outcomes", encompasses (1) the classification/ diagnostics of post-COVID-19 condition, (2) somatic symptoms (including fatigue), (3) the psychopathological status and mental comorbidities, (4) the physical status and somatic comorbidities, (5) neurocognitive symptoms, and (6) illness consequences. The second higher-order domain "mechanisms" encompasses (7) cognitive components, (8) affective components, (9) behavioral components, (10) social components, and (11) psychobiological bridge markers (e.g., neuroimmunological and psychoneuroendocrinological variables). The third higher-order domain, "risk factors", includes factors such as (12) socioeconomic status and sociocultural factors, (13) pre-existing mental and somatic health issues, (14) personality factors (e.g., neuroticism), (15) adverse childhood experiences, (16) ongoing disability or pension claim, and (17) social media use. For each domain, specific instruments are suggested for research purposes and clinical use.
The recommended core domains help to increase consistency in a biopsychosocial approach to post-COVID-19 condition across investigations, improve synergies, and facilitate decision-making when comparing different interventional approaches. It allows to better identify relevant subgroups in heterogeneous post-COVID-19 condition populations offering practical tools for routine clinical practice through the clinical core set.
协调核心结局领域有助于汇总数据、比较干预措施并简化研究评估。与此同时,临床医生需要简洁且可行的措施用于日常实践。考虑到新冠后状况的异质性,生物心理社会方法需要通过评估充分涵盖心理社会维度。先前关于核心结局集的建议在新冠后状况的心理社会方面存在严重局限性。本文特别关注新冠后状况成人的心理社会结局,既提供了一套全面的研究结局领域,又提供了一套为日常临床使用量身定制的简化临床核心集。
在一种结构化的共识发展方法中,欧洲改善持续性躯体症状患者诊断、治疗和医疗保健网络(EURONET - SOMA)制定了关于新冠后状况的心理社会核心结局领域及评估。专家们确定了在研究新冠后状况成人时应考虑的变量和工具,这些变量和工具在临床环境中可行且与研究相关。
我们确定了三个高阶维度,每个维度包含几个领域:第一个高阶维度“结局”包括(1)新冠后状况的分类/诊断,(2)躯体症状(包括疲劳),(3)精神病理状态和精神共病,(4)身体状况和躯体共病,(5)神经认知症状,以及(6)疾病后果。第二个高阶领域“机制”包括(7)认知成分,(8)情感成分,(9)行为成分,(10)社会成分,以及(11)心理生物学桥梁标志物(如神经免疫学和心理神经内分泌学变量)。第三个高阶领域“风险因素”包括诸如(12)社会经济地位和社会文化因素,(13)既往的心理和躯体健康问题,(14)人格因素(如神经质),(15)童年不良经历,(16)持续的残疾或养老金申领,以及(17)社交媒体使用等因素。针对每个领域,建议了用于研究目的和临床使用的特定工具。
推荐的核心领域有助于在对新冠后状况的生物心理社会方法的各项研究中提高一致性,改善协同作用,并在比较不同干预方法时促进决策制定。它有助于在异质性的新冠后状况人群中更好地识别相关亚组,并通过临床核心集为日常临床实践提供实用工具。